Premium
Sustained oral lysine supplementation in ornithine δ‐aminotransferase deficiency
Author(s) -
Elpeleg O. N.,
Korman S. H.
Publication year - 2001
Publication title -
journal of inherited metabolic disease
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 102
eISSN - 1573-2665
pISSN - 0141-8955
DOI - 10.1023/a:1010545811361
Subject(s) - lysine , ornithine , human genetics , medicine , metabolic disease , ornithine aminotransferase , biochemistry , endocrinology , biology , chemistry , arginine , amino acid , gene
Oral lysine administration to three patients with B6-nonresponsive gyrate atrophy reduced plasma ornithine concentrations by 21-31% within 1-2 days. No further reduction was noted with time.